Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

RheumPAC: A Wise Investment to Let Your Voice Be Heard in Washington, D.C.

From the College  |  Issue: April 2021  |  April 5, 2021

Often, lawmakers are unaware of how much rheumatic disease affects Americans and the disparity in research funding for these conditions. Having frequent conversations with lawmakers helps bring awareness, and RheumPAC donations promote those lawmakers who support our issues.

Kristine Kuhn, MD, PhD
University of Colorado Anschutz Medical Campus
Aurora

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Resonance

Rheumatologists need to understand that RheumPAC is one of the only mechanisms whereby we can try to influence and affect the opinions of our legislators with regard to issues that are critical to the survival and well-being of all rheumatology providers and their patients.

Although we cannot compare our financial clout to that of the insurance, pharmaceutical and other special interest groups, our voice carries a much louder resonance with lawmakers because of RheumPAC, which can convey to lawmakers the number of constituents affected and the need to take care of their issues.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

RheumPAC serves every rheumatologist’s well-being as demonstrated by—among other successes—recent reimbursement changes in our favor and the success of our advocacy showing that the implementation of proposed revisions to reimbursement guidelines for in-office infusion and other treatments would have closed practices.

Keeping RheumPAC well funded is critical and essential to our survival as a specialty.

Norman Gaylis, MD
Arthritis & Rheumatic Disease Specialties
Aventura, Fla.

Stewardship

The advocacy work of the College through RheumPAC is essential and offers an opportunity to engage with legislative leaders and discuss issues important to our patients and the entire rheumatology team caring for them.

My time and financial commitment to these efforts provide personal and professional satisfaction, as we strive to improve the lives of our patients and our ability to care for them with dignity, equality and respect.

I also appreciate the judicious stewardship decisions of RheumPAC when using my financial contributions to help meet the needs of all College stakeholders.

Hazel Breland, PhD, OTR/L, FAOTA, CLA
Medical University of South Carolina
Columbia

Relationships

I donate to RheumPAC because I have seen firsthand how it creates relationships between the ACR and lawmakers. These relationships allow our advocates to find out what is happening on Capitol Hill and intervene on behalf of our profession and our patients. This year, for example, CMS raised reimbursement for the care we provide and paused the latest ill-conceived demonstration project that would have cut infusion services we provide—all as a result of tireless advocacy of many people.

Even the most well-meaning government officials will always require our input about the complex nature of our work in the context of the larger U.S. medical system. RheumPAC helps us provide that critical input.

Page: 1 2 3 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:AdvocacyRheumPAC

Related Articles

    State of RheumPAC: 2015 Annual Report

    May 13, 2016

    Dear Friends and Colleagues, With your strong support and commitment, RheumPAC has grown again for the eighth straight year, allowing us to do even more on your behalf. Not only did we exceed our original goal by raising more than $150,000. More importantly, these donations came from nearly 350 ACR and ARHP members—a new record….

    Advancing the ACR’s Legislative Priorities in 2021

    January 11, 2021

    With a new Congress and many new legislators in key leadership positions, your support today will help RheumPAC start the year off strong.

    PAC Progress and Challenges

    November 1, 2009

    After three years, RheumPAC has a solid start, and more work ahead of it

    A Huge Thank You to 251 People

    March 18, 2011

    RheumPAC supporters are helping to advance rheumatology

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences